Literature DB >> 27909823

Gelatin microspheres containing calcitonin gene-related peptide or substance P repair bone defects in osteoporotic rabbits.

Jianghao Chen1, Wei Liu1, Jinxiu Zhao2, Cong Sun2, Jie Chen1, Kaijin Hu1, Linlin Zhang1, Yuxiang Ding3.   

Abstract

OBJECTIVES: To investigate the therapeutic effect of gelatin microspheres containing different concentrations of calcitonin gene-related peptide (CGRP) or substance P on repairing bone defects in a rabbit osteoporosis model.
RESULTS: Gelatin microspheres containing different concentrations of CGRP or substance P promoted osteogenesis after 3 months in a rabbit osteoporotic bone defective model. From micro-computed tomography imaging results, 10 nM CGRP was optimal for increasing the trabecular number and decreasing the trabecular bone separation degree; similar effects were observed with the microspheres containing 1 µM substance P. Histological analysis showed that the gelatin microspheres containing CGRP or substance P, regardless of the concentration, effectively promoted osteogenesis, and the highest effect was achieved in the groups containing 1 µM CGRP or 1 µM substance P.
CONCLUSIONS: Gelatin microspheres containing CGRP or substance P effectively promoted osteogenesis in a rabbit osteoporotic bone defect model dose-dependently, though their effects in repairing human alveolar ridge defects still need further investigation.

Entities:  

Keywords:  Bone defect; Bone repair; Calcitonin gene-related peptide; Gelatin microspheres; Osteoporosis; Substance P

Mesh:

Substances:

Year:  2016        PMID: 27909823     DOI: 10.1007/s10529-016-2263-4

Source DB:  PubMed          Journal:  Biotechnol Lett        ISSN: 0141-5492            Impact factor:   2.461


  8 in total

1.  CGRP gene-modified rBMSCs show better osteogenic differentiation capacity in vitro.

Authors:  Xijiao Yu; Shuang Liu; Hui Chen; Xinyu Zhao; Xue Chen; Yi Du; Shu Li
Journal:  J Mol Histol       Date:  2018-05-30       Impact factor: 2.611

Review 2.  No pain, no gain? The effects of pain-promoting neuropeptides and neurotrophins on fracture healing.

Authors:  Seungyup Sun; Nicklaus H Diggins; Zachary J Gunderson; Jill C Fehrenbacher; Fletcher A White; Melissa A Kacena
Journal:  Bone       Date:  2019-11-09       Impact factor: 4.398

Review 3.  Rabbit as model for osteoporosis research.

Authors:  María Permuy; Mónica López-Peña; Fernando Muñoz; Antonio González-Cantalapiedra
Journal:  J Bone Miner Metab       Date:  2019-05-13       Impact factor: 2.626

Review 4.  Substance P, A Promising Therapeutic Target in Musculoskeletal Disorders.

Authors:  Kyung Rae Ko; Hyunil Lee; Soo-Hong Han; Wooyeol Ahn; Do Kyung Kim; Il-Su Kim; Bo Sung Jung; Soonchul Lee
Journal:  Int J Mol Sci       Date:  2022-02-26       Impact factor: 5.923

5.  Implantable Electrical Stimulation at Dorsal Root Ganglions Accelerates Osteoporotic Fracture Healing via Calcitonin Gene-Related Peptide.

Authors:  Jie Mi; Jian-Kun Xu; Zhi Yao; Hao Yao; Ye Li; Xuan He; Bing-Yang Dai; Li Zou; Wen-Xue Tong; Xiao-Tian Zhang; Pei-Jie Hu; Ye Chun Ruan; Ning Tang; Xia Guo; Jie Zhao; Ju-Fang He; Ling Qin
Journal:  Adv Sci (Weinh)       Date:  2021-10-28       Impact factor: 16.806

6.  A biomimetic and bioactive scaffold with intelligently pulsatile teriparatide delivery for local and systemic osteoporosis regeneration.

Authors:  Lingbin Che; Ying Wang; Dongyong Sha; Guangyi Li; Ziheng Wei; Changsheng Liu; Yuan Yuan; Dianwen Song
Journal:  Bioact Mater       Date:  2022-04-05

Review 7.  The Role of Substance P in the Regulation of Bone and Cartilage Metabolic Activity.

Authors:  Fu-Xing-Zi Li; Feng Xu; Xiao Lin; Feng Wu; Jia-Yu Zhong; Yi Wang; Bei Guo; Ming-Hui Zheng; Su-Kang Shan; Ling-Qing Yuan
Journal:  Front Endocrinol (Lausanne)       Date:  2020-02-28       Impact factor: 5.555

8.  Calcitonin Gene-Related Peptide Influences Bone-Tendon Interface Healing Through Osteogenesis: Investigation in a Rabbit Partial Patellectomy Model.

Authors:  Huabin Chen; Hongbin Lu; Jianjun Huang; Zhanwen Wang; Yang Chen; Tao Zhang
Journal:  Orthop J Sports Med       Date:  2021-07-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.